With 91 candidates leveraging 12 different immunisation technologies currently in development by our member companies, the report highlights the pivotal role innovation in #immunisation plays in addressing emerging and persistent health threats.

One hurdle being that #vaccines are underfunded and their value is underestimated. He noted that data sharing is the first step to data integration, and concluded by saying that the first challenge of AMR is the resistance of humans to change @escmid.bsky.social

Finally, Tochi Okwor from the Nigeria Center for Disease Control and Prevention highlighted that from a practical perspective and based on existing evidence, #vaccination is a simple intervention leveraging existing resources.

Chantal Morel from the KPM Center for Health management reminded all that collecting data requires well functioning health systems and Joseph Lewnard remarked that hospital-based sentinels systems and microbiology labs would support appropriate attribution of AMR-related deaths.

He added that beyond bacterial pathogens, viral infections such as influenza, rotavirus or RSV are responsible for a significant proportion of antibiotic use - by preventing disease, #vaccines can reduce the need for treatment and the risk of secondary infections, relieving selective pressure.